BCMA/CD19 CAR-T cells

BCMA/CD19 chimeric antigen receptor T cells · Essen Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCMA/CD19 CAR-T cells, covering 2024-11-05 to 2024-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases [Phase 1, Phase 2]

See pricing